Skullcapflavone II inhibits ovalbumin-induced airway inflammation in a mouse model of asthma

被引：62

作者：

Jang, Ha-Young ^{[1
]}

Ahn, Kyung-Seop ^{[1
]}

Park, Mi-Jeong ^{[1
]}

Kwon, Ok-Kyoung ^{[1
]}

Lee, Hyeong-Kyu ^{[1
]}

Oh, Sei-Ryang ^{[1
]}

机构：

[1] Korea Res Inst Biosci & Biotechnol, Nat Med Res Ctr, Cheongwon Gun 363883, Chungbuk, South Korea

来源：

INTERNATIONAL IMMUNOPHARMACOLOGY | 2012年 / 12卷 / 04期

关键词：

Skullcapflavone II; Asthma; Scutellaria baicalensis Georgi; GROWTH-FACTOR-BETA; T-CELLS; SCUTELLARIA-BAICALENSIS; EXPRESSION; INTERLEUKIN-13; HYPERRESPONSIVENESS; HYPERREACTIVITY; RESPONSIVENESS; PATHOGENESIS; KININ;

D O I：

10.1016/j.intimp.2012.01.010

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

Skullcapflavone II is a flavonoid derived from Scutellaria baicalensis, a widely used herbal medicine in anti-inflammatory and anticancer therapy in Korea. Skullcapflavone II antagonized the bradykinin receptor more potently than any of the other flavonoids derived from this plant. Here, we were investigated its therapeutic effects in a mouse model of ovalbumin (OVA)-induced allergic asthma. Administration of skullcapflavone II significantly reduced airway hyperresponsiveness (AHR), airway eosinophilia, Th2 cytokine production, and increased transforming growth factor-beta 1 (TGF-beta 1) levels in bronchoalveolarlavage (BAL) fluids and lungs from OVA-sensitized and -challenged mice. Skullcapflavone II administration also significantly suppressed subepithelial collagen deposition and goblet cell hyperplasia, elevated Smad7 expression and suppressed pSmad2/3 levels. Collectively, these findings indicate that skullcapflavone II, a potential bradykinin antagonist, reduced the major pathophysiological features of allergic asthma, at least in part by acting on TGF-beta 1/Smad signaling pathways. Thus, skullcapflavone II may have therapeutic potential for the treatment of allergic asthma. (C) 2012 Elsevier B.V. All rights reserved.

引用

页码：666 / 674

页数：9

共 40 条

[1]

CIRCULATING PLASMA KININ IN PATIENTS WITH BRONCHIAL ASTHMA [J].